COHEN IRUN R has a total of 31 patent applications. Its first patent ever was published in 1990. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, measurement and biotechnology are GUDKOV ANDREI V, QI HAIYAN and BRNI NEUROSCIENCES INST.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 15 | |
#2 | WIPO (World Intellectual Property Organization) | 8 | |
#3 | EPO (European Patent Office) | 4 | |
#4 | Canada | 2 | |
#5 | Australia | 1 | |
#6 | China | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Measurement | |
#3 | Biotechnology | |
#4 | Computer technology | |
#5 | Environmental technology | |
#6 | Machines |
# | Name | Total Patents |
---|---|---|
#1 | Cohen Irun R | 30 |
#2 | Mor Felix | 8 |
#3 | Quintana Francisco J | 7 |
#4 | Carmi Pnina | 6 |
#5 | Quintana Francisco Javier | 5 |
#6 | Domany Eytan | 3 |
#7 | Lohse Ansgar W | 2 |
#8 | Markovits Doron | 2 |
#9 | Elias Dana | 2 |
#10 | Javier Quintana Francisco | 2 |
Publication | Filing date | Title |
---|---|---|
WO2011064779A2 | Peptides derived from hiv-1 gp41 transmembrane for t - immunomodulation | |
WO2009090650A2 | Vaccine for alzheimer's disease | |
WO2009034574A2 | Methods of treating tumors in immune-privileged sites | |
US2009269370A1 | Vaccines comprising multimeric HSP60 peptide carriers | |
US2010003225A1 | HSP60, HSP60 peptides and T cell vaccines for immunomodulation | |
WO2006067792A2 | Aldolase autoantigens useful in diagnosis and treatment of alzheimer's disease | |
US2005260770A1 | Antigen array and diagnostic uses thereof | |
US2006221081A1 | Reactive animation | |
EP1575526A2 | Dna vaccines encoding heat shock proteins | |
CA2032138A1 | Anti-ergotypic t cells for the treatment or prevention of autoimmune diseases and methods of use thereof |